BioSpace News Archive

Data show this new option can help some metastatic NSCLC patients live significantly longer

RegeneRx Biopharmaceuticals, Inc. announced that GtreeBNT, its licensee for RGN-137 topical wound healing gel, has initiated administration of the product candidate to the first patient in a randomized, single-masked, placebo-controlled, self-matched pairing, independently-evaluated phase 2 study for EB in the U.S. RGN-137 is a formulation of thymosin beta 4 designed for dermatological wound healing.

Pi Therapeutics announced the completion of a $19.7 million Series B financing.

Cloud-Connected, Smart Shippers and evo.is Real-Time Visibility Platform Improve Quality of Transportation and Delivery of Lifesaving Therapies

A bioengineered human acellular vessel may help veterans with kidney failure

Collaboration Aims to Study Variation in Cancer Treatment Patterns by Extracting and Analyzing Real-World Data

InVivo Therapeutics Holdings Corp. announced that the first two patients have been enrolled into The INSPIRE 2.0 Study.

The Michigan Mesothelioma Victims Center says we are urging a US Navy Veteran or a factory worker anywhere in Michigan with recently diagnosed mesothelioma to call us anytime at 800-714-0303.

The Corporate Whistleblower Center says, “We have one of the most aggressive initiatives in the nation focused of federal taxpayers being ripped off with waste, abuse and fraud.

Robert “Bob” Ficarra, an active board member of The Cooley’s Anemia Foundation and son of Cooley’s Anemia Foundation founder Frank Ficarra, and Maria Hadjidemetriou, a thalassemia patient and activist, will be honored by the Cooley’s Anemia Foundation at its annual Gala on Thursday, June 6, 2019 at the Lighthouse at Chelsea Piers in Manhattan.